# Keith Pfeil

> Keith W. Pfeil is president, chief executive officer and a director of Globus Medical. Appointed CEO in July 2025, he joined as CFO in August 2019 and added the COO role in February 2024. He helped lead the NuVasive acquisition and integration after a finance career spanning CSS Industries, Ernst & Young, KPMG and Arthur Andersen.

- **Role:** President and Chief Executive Officer at Globus Medical
- **Organizations:** Globus Medical, CSS Industries, Ernst & Young, KPMG, Arthur Andersen
- **Education:** B.S. in Accounting, Elizabethtown College, Executive MBA, Saint Joseph’s University
- **Known for:** Rose from financial analysis manager to CFO at CSS Industries., Helped lead Globus Medical’s NuVasive acquisition and integration., Expanded from CFO to combined COO/CFO and then president and CEO at Globus Medical.

## Career timeline

- **2003** — Joined CSS Industries as manager of financial analysis at Paper Magic Group.
- **2013** — Became vice president of financial planning and analysis at Paper Magic Group.
- **2017** — Became senior vice president of financial planning and analysis and investor relations at CSS Industries.
- **2018-08-31** — Appointed executive vice president-finance and CFO of CSS Industries.
- **2019-08-19** — Joined Globus Medical as senior vice president and CFO.
- **2023** — Helped lead the NuVasive acquisition and served on the executive steering committee for integration; merger completed September 1.
- **2024-02-01** — Became COO and CFO of Globus Medical; appointment announced February 5.
- **2025-07-18** — Appointed president and CEO of Globus Medical and joined its board; announced July 21.

## Achievements

- Rose from financial analysis manager to CFO at CSS Industries.
- Helped lead Globus Medical’s NuVasive acquisition and integration.
- Expanded from CFO to combined COO/CFO and then president and CEO at Globus Medical.

## Latest updates

- **2026-08** — As president and CEO, commented on second-quarter results: worldwide net sales of $789.6 million, up 5.9%; company maintained 2026 revenue guidance of $3.18 billion to $3.22 billion.
- **2026-02** — Discussed 2025 results: $2.9389 billion in annual net sales, up 16.7%, and base-business growth excluding Nevro of 5.0%.
- **2025-07** — Became president, CEO and a director of Globus Medical effective July 18.

## Links

- Website: https://www.investors.globusmedical.com/board-member/keith-pfeil
- LinkedIn: https://www.linkedin.com/in/keith-pfeil-088b361

---

Profile page: https://yespress.io/keith-pfeil
Published by YesPress — https://yespress.io
Last updated: 2026-10-23